Form 4: Saba Capital Management Sells Shares of BlackRock Capital Allocation Term Trust

Sentiment:

SEC Form 4 Filing


Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, sold 7,396 shares of common stock at $14.82 per share on March 17, 2025.

Summary

  • On March 17, 2025, Saba Capital Management, L.P. sold 7,396 shares of BlackRock Capital Allocation Term Trust (BCAT) common stock.
  • The sale price was $14.82 per share.
  • Following the transaction, Saba Capital Management, L.P. indirectly owns 11,811,352 shares of BCAT.
  • Boaz Weinstein, also a reporting person, is associated with this transaction.

Sentiment

Score: 5

Explanation: The document is a neutral report of a transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This transaction is a routine disclosure of stock trading activity by a major shareholder, Saba Capital Management, in BlackRock Capital Allocation Term Trust. It provides transparency into the investment decisions of significant stakeholders.

Stakeholder Impact

  • The sale of shares by a major shareholder like Saba Capital Management could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding.

Key Dates

DateDescription
03/17/2025Date of transaction: Saba Capital Management sold shares of BCAT
03/18/2025Date of signature for Saba Capital Management and Boaz Weinstein

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.